Nuclear Medicine: Page 39

Sun Nuclear launches new facility in the Netherlands

By AuntMinnie.com staff writers

Radiation oncology software developer Sun Nuclear has opened a new facility in Breda, the Netherlands.

March 28, 2021

Researchers design 8-ring SPECT-CZT camera

By Will Morton

Looking to take SPECT to the next level, researchers are developing a new system based on eight digital cadmium zinc telluride (CZT) detectors surrounding the patient. The system could offer faster scans and better image quality in patients, especially those with brain conditions.

March 28, 2021

Isotopia to supply MTTI with Lu-177

By AuntMinnie.com staff writers

Isotopia Molecular Imaging announced it has inked a deal to supply biopharmaceutical company Molecular Targeting Technologies (MTTI) with its lutetium-177 (Lu-177) medical isotope for the development of new targeted radiotherapeutics.

March 25, 2021

Dutch look for answers to fix nuclear medicine training

By Will Morton

Is there a way to stem the declining numbers of residents pursuing specialties in nuclear medicine in Europe and the U.S.? In a recent survey, Dutch researchers sought insights from residents on how to fix nuclear medicine training.

March 25, 2021

IBA reports revenue rebound in 2020

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) bounced back with growth of 10.4% in revenues in 2020 after reporting reduced revenues for the first half of the year due to challenges presented by the COVID-19 pandemic.

March 24, 2021

Novartis touts phase III prostate cancer study results

By AuntMinnie.com staff writers

Novartis is highlighting results from a phase III study that has investigated the efficacy and safety of Lu-177 PSMA-617, a radioligand therapy for patients with prostate-specific membrane antigen-positive metastatic prostate cancer.

March 22, 2021

New radiotracer for neuroendocrine tumors appears safe

By Will Morton

A new radiopharmaceutical based on lutetium-177 being tested for the treatment of neuroendocrine tumors is safe and effective and may allow physicians to cut the radiation dose patients receive by half, according to a study published online March 19 in the Journal of Nuclear Medicine.

March 22, 2021

Novel radiotracer shows promise for prostate imaging

By Will Morton

An experimental new radiotracer is effective when used with PET/CT for detecting biochemically recurrent prostate cancer and may change patient management, according to research published online March 12 in the Journal of Nuclear Medicine.

March 21, 2021

Mich. cardiologist pays $2M to settle billing case

By AuntMinnie.com staff writers

A Michigan cardiologist and his practice paid the U.S. government $2 million to resolve allegations they violated the False Claims Act by knowingly billing federal healthcare programs for diagnostic testing that was either unnecessary or not performed.

March 18, 2021

BWXT, GMS form joint venture for Asia-Pacific

By AuntMinnie.com staff writers

BWX Technologies (BWXT) subsidiary and medical isotope and radiopharmaceutical supplier BWXT Medical has formed a joint venture for the Asia-Pacific region with nuclear medicine and radiopharmacy firm Global Medical Solutions (GMS).

March 8, 2021

NorthStar, IBA expand Tc-99m collaboration

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and proton therapy developer Ion Beam Applications (IBA) are expanding their collaboration in an effort to increase the supply of technetium-99m (Tc-99m) around the world.

March 7, 2021

Navidea signs deal for $5M in preferred shares

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has signed an agreement with the company's largest shareholder for a private placement of up to $5 million in preferred stock.

March 4, 2021

Previous Page

Page 39 of 440

Next Page